Estrella Immunopharma Inc... (ESLA)
NASDAQ: ESLA
· Real-Time Price · USD
1.19
0.01 (0.85%)
At close: Sep 24, 2025, 3:59 PM
1.18
-0.52%
After-hours: Sep 24, 2025, 04:04 PM EDT
0.85% (1D)
| Bid | 1.1 |
| Market Cap | 43.97M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -12.08M |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | -4.94 |
| Forward PE | n/a |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.25 |
| Volume | 37,863 |
| Avg. Volume (20D) | 22,890 |
| Open | 1.20 |
| Previous Close | 1.18 |
| Day's Range | 1.09 - 1.25 |
| 52-Week Range | 0.63 - 1.78 |
| Beta | 0.37 |
| Ex-Dividend Date | n/a |
About ESLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ESLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ESLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-14%
ESLA stock has given up its prior gain. Estrella I...
Unlock content with
Pro Subscription
3 months ago
-14%
Estrella Immunopharma shares are trading higher. The company anounced an approximate $3.35 million private placement equity financing of 2,333,334 shares of its stock at $1.50 per share.
